Elucidating factors that modulate mammalian DNA repair to improve genome editing
阐明调节哺乳动物 DNA 修复的因素以改善基因组编辑
基本信息
- 批准号:10712484
- 负责人:
- 金额:$ 38.88万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-08-01 至 2028-05-31
- 项目状态:未结题
- 来源:
- 关键词:AccelerationAddressCRISPR/Cas technologyCell physiologyCellsDNA RepairDNA Repair PathwayDependenceDouble Strand Break RepairEquilibriumGenetic DiseasesGoalsHealthHistonesHumanIndividualLaboratoriesMethodsMissionOutcomePatternPeptidesProcessPropertyProteomePublic HealthResearchRoleSiteTherapeuticTranscriptional RegulationUnited States National Institutes of HealthWorkcell typegenome editinghistone modificationimprovedinnovationprotein protein interactionrare genetic disorderrecruitscreeningtherapeutic developmenttherapeutic genome editing
项目摘要
Project Summary/Abstract
Genome editing is an exciting avenue for treating common and rare genetic diseases, and the advent of
CRISPR/Cas technologies has accelerated the development of this therapeutic option. These therapies rely on
cellular DNA repair machinery to install their edits, so changes in the balance between DNA repair pathways
result in different editing patterns. This dependency on endogenous DNA repair has led to considerable variability
in editing efficiency between cell types or even among targets in the same cell. Thus, a long-term goal of my
laboratory is to investigate factors that modify the efficacy of genome editing and to develop strategies that
address these shortcomings. Histone modifications play a role in many cellular processes, including
transcriptional regulation and DNA repair. Recent evidence found that histone modifications correlate with biases
for specific DNA repair pathways. However, given their role in multiple processes, interpreting the effects of
individual histone modifications has been challenging. I will dissect these effects to define the role of histone
modifications in the repair of double-strand breaks by innovating a platform that recruits histone modifiers to
thousands of break sites in parallel. This work will determine whether histone modifications influence DNA repair
and uncover properties of the target site that predict these effects. For genome editing to reach its therapeutic
potential, precise control of DNA repair is required. I will identify peptides from the human proteome that alter
the repair of double-strand breaks. To do this, I will adapt a peptide screening platform I developed to investigate
DNA repair. The peptides will reveal critical protein-protein interactions and other methods for altering DNA
repair. The completion of these projects will significantly advance our understanding of mammalian DNA repair
and has the potential to improve genome editing therapies.
项目摘要/摘要
基因组编辑是治疗常见和罕见遗传病的一种令人兴奋的途径,而
CRISPR/CAS技术加速了这一治疗方案的发展。这些疗法依赖于
细胞DNA修复机制安装它们的编辑,使DNA修复途径之间的平衡发生变化
导致不同的编辑模式。这种对内源性DNA修复的依赖导致了相当大的变异性
在单元类型之间甚至同一单元中的目标之间的编辑效率方面。因此,我的一个长期目标是
实验室的任务是调查改变基因组编辑效果的因素,并制定策略
解决这些缺点。组蛋白修饰在许多细胞过程中发挥作用,包括
转录调控和DNA修复。最近的证据发现,组蛋白修饰与偏向有关
用于特定的DNA修复途径。然而,考虑到它们在多个过程中的作用,解释
单独的组蛋白修饰一直是具有挑战性的。我将剖析这些影响,以确定组蛋白的作用
通过创新一个招募组蛋白修饰剂的平台来修改双链断裂的修复
数以千计的休息点并行。这项工作将确定组蛋白修饰是否会影响DNA修复
并揭示预测这些影响的目标站点的属性。使基因组编辑达到其治疗效果
需要对DNA修复进行潜在的、精确的控制。我将从人类蛋白质组中鉴定出可以改变
双链断裂的修复。为此,我将采用我开发的一个肽筛选平台来研究
DNA修复。这些多肽将揭示关键的蛋白质-蛋白质相互作用和其他改变DNA的方法
修理。这些项目的完成将极大地促进我们对哺乳动物DNA修复的理解
并有可能改进基因组编辑疗法。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Gaelen T Hess其他文献
Gaelen T Hess的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 38.88万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 38.88万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 38.88万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 38.88万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 38.88万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 38.88万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 38.88万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 38.88万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 38.88万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 38.88万 - 项目类别:
Research Grant